| CXSB2000019 | 重组抗HER2结构域II人源化单克隆抗体注射液 | | Injection | Biological Products | Supplementary Application | 2020-06-18 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-06-17 | view |
| CXSL1900139 | 重组抗HER2结构域II人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2019-12-20 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd;The New Drug Research and Development Co Ltd Beijing History | In Review | 2019-12-18 | view |
| CXSL1900122 | 重组抗HER2结构域II人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2019-11-05 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2019-11-04 | view |
| CXSB2300131 | 重组抗HER2结构域II人源化单克隆抗体注射液 | | Injection | Biological Products(3.3) | Supplementary Application | 2023-11-17 | | Shanghai Henlius Biopharmaceutical Co Ltd;Shanghai Henlius Biotech Co Ltd | | | view |
| CXSB2200010 | 重组抗HER2结构域II人源化单克隆抗体注射液 | | Injection | Biological Products(3.3) | Supplementary Application | 2022-01-25 | | Shanghai Henlius Biologics Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd;Shanghai Henlius Biotech Co Ltd | | | view |
| CXSL1400157 | 重组抗HER2结构域Ⅱ人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2015-02-26 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2016-05-19 | view |
| CXSL1600001 | 重组抗HER2结构域Ⅱ人源化单克隆抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2016-03-30 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2016-12-08 | view |
